Literature DB >> 9655179

Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta.

S Mittra1, M Singh.   

Abstract

The mechanism of captopril, an angiotensin converting enzyme (ACE) inhibitor with sulfhydryl group (SH) in its structure, to produce an endothelium-dependent vasorelaxation was studied. In rabbit aorta with intact endothelium and precontracted with phenylephrine, captopril and superoxide dismutase (SOD) produced dose-dependent relaxation. Lisinopril, an ACE inhibitor without a -SH group in its structure, did not produce endothelium-dependent relaxation. It was observed that captopril, like SOD, produced the relaxation by protecting the EDRF from getting inactivated by superoxide anions as pyrogallol and methylene blue inhibited both the captopril and SOD-mediated relaxation. The free radical scavenging action of captopril is further substantiated by the observation that captopril, but not lisinopril, inhibited FeCl3/ascorbic acid-induced lipid peroxidation in whole tissue homogenates of rabbit aorta to a level comparable to that of SOD. These results suggest that endothelium-dependent vasodilation produced by captopril may be due to its ability to scavenge superoxide anion and this property may be ascribed to the -SH group present in its structure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9655179     DOI: 10.1023/a:1006854313163

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  21 in total

1.  Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation.

Authors:  J M Braughler; J F Pregenzer; R L Chase; L A Duncan; E J Jacobsen; J M McCall
Journal:  J Biol Chem       Date:  1987-08-05       Impact factor: 5.157

2.  Nitric oxide inactivates endothelium-derived contracting factor in the rat aorta.

Authors:  W Auch-Schwelk; Z S Katusić; P M Vanhoutte
Journal:  Hypertension       Date:  1992-05       Impact factor: 10.190

3.  Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor.

Authors:  D Bagchi; R Prasad; D K Das
Journal:  Biochem Biophys Res Commun       Date:  1989-01-16       Impact factor: 3.575

4.  Endothelial renin-angiotensin pathway. Adrenergic regulation of angiotensin secretion.

Authors:  S S Tang; L Stevenson; V J Dzau
Journal:  Circ Res       Date:  1990-01       Impact factor: 17.367

5.  Captopril decreases vascular reactivity independently of changes in converting enzyme activity and prostaglandin release in the rat isolated kidney.

Authors:  S Chiba; C P Quilley; J Quilley; J C McGiff
Journal:  Eur J Pharmacol       Date:  1982-09-24       Impact factor: 4.432

6.  Effects of captopril on vascular reactivity of SHR in vivo and in vitro.

Authors:  M J Antonaccio; B Rubin; D Kotler
Journal:  Hypertension       Date:  1981 Nov-Dec       Impact factor: 10.190

7.  Methylene blue inhibits nitrovasodilator- and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion.

Authors:  N Marczin; U S Ryan; J D Catravas
Journal:  J Pharmacol Exp Ther       Date:  1992-10       Impact factor: 4.030

8.  High-molecular weight kininogen is present in cultured human endothelial cells: localization, isolation, and characterization.

Authors:  F van Iwaarden; P G de Groot; J J Sixma; M Berrettini; B N Bouma
Journal:  Blood       Date:  1988-05       Impact factor: 22.113

9.  Captopril attenuates adrenergic vasoconstriction in rat mesenteric arteries by angiotensin-dependent and -independent mechanisms.

Authors:  M G Collis; J R Keddie
Journal:  Clin Sci (Lond)       Date:  1981-09       Impact factor: 6.124

10.  Captopril: a free radical scavenger.

Authors:  M Chopra; N Scott; J McMurray; J McLay; A Bridges; W E Smith; J J Belch
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

View more
  10 in total

Review 1.  NO and the vasculature: where does it come from and what does it do?

Authors:  Karen L Andrews; Chris R Triggle; Anthie Ellis
Journal:  Heart Fail Rev       Date:  2002-10       Impact factor: 4.214

2.  Effect of bis(maltolato) oxovanadium on experimental vascular endothelial dysfunction.

Authors:  Dhvanit I Shah; Manjeet Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-03       Impact factor: 3.000

3.  Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.

Authors:  Sonam Kathuria; Nanjaian Mahadevan; Pitchai Balakumar
Journal:  Mol Cell Biochem       Date:  2012-11-10       Impact factor: 3.396

4.  Kaempferol enhances endothelium-independent and dependent relaxation in the porcine coronary artery.

Authors:  Y C Xu; D K Y Yeung; R Y K Man; S W S Leung
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

5.  Involvement of Rho-kinase in experimental vascular endothelial dysfunction.

Authors:  Dhvanit I Shah; Manjeet Singh
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

6.  Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats.

Authors:  Dhvanit I Shah; Manjeet Singh
Journal:  Mol Cell Biochem       Date:  2006-07-14       Impact factor: 3.396

7.  Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.

Authors:  Uma Jyoti; Sunil Kumar Kansal; Puneet Kumar; Sandeep Goyal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02       Impact factor: 3.000

8.  Construction of time-response curve for neuronal and vascular endothelial dysfunction in ovariectomized rats.

Authors:  Seema Bansal; Kanwaljit Chopra
Journal:  Indian J Pharmacol       Date:  2021 Jan-Feb       Impact factor: 1.200

9.  Antioxidant effect of captopril and enalapril on reactive oxygen species-induced endothelial dysfunction in the rabbit abdominal aorta.

Authors:  Ji Hoon Kim; Hyuck Kim; Young Hak Kim; Won-Sang Chung; Jung Kook Suh; Sung Jin Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-02-06

10.  Vasorelaxing and antihypertensive activities of synthesized peptides derived from computer-aided simulation of pepsin hydrolysis of yam dioscorin.

Authors:  Yin-Shiou Lin; Yeh-Lin Lu; Guei-Jane Wang; Hong-Jen Liang; Wen-Chi Hou
Journal:  Bot Stud       Date:  2014-06-07       Impact factor: 2.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.